title: Isolation and cardiovascular activity of a second bradykinin-related peptide ([Arg0, Trp5, Leu8]bradykinin) from trout.
abstract: Previous work has shown that incubation of heat-denatured plasma from the rainbow trout Oncorhynchus mykiss with porcine pancreatic kallikrein generates [Lys0, Trp5, Leu8]bradykinin (trout [Lys0]BK). We have now isolated a second BK-related peptide from kallikrein-treated trout plasma with the primary structure: Arg-Arg-Pro-Gly-Trp-Ser-Pro-Leu-Arg (trout [Arg0]BK). Bolus injections of both trout [Arg0]BK and [Lys0]BK (> 100 pmol/kg) into the dorsal aorta of conscious trout produced multiphasic effects on arterial blood pressure. An initial pressor response of short duration (1-2 min) was followed by a fall in pressure (to below basal values in 11 out of 15 animals) and then by a sustained rise in pressure lasting up to 60 min. The maximum rise in pressure produced by trout [Arg0]BK (10 nmol/kg) was approximately one-fourth of the maximum rise produced by angiotensin II in the same animals. Intracerebroventricular injections of trout [Arg0]BK (500 pmol) into conscious trout had no effect on arterial blood pressure or heart rate. Trout [Arg0]BK did not affect the tension of vascular rings from trout efferent branchial and caeliacomesenteric arteries and anterior cardinal vein. Trout des [Arg9]BK had no effect on cardiovascular parameters, either in vivo or in vitro, indicating that the C-terminal arginine residue of the peptide is important in interaction with the trout kinin receptor(s).
authors: Department of Biomedical Sciences, Creighton University School of Medicine, Omaha, NE 68178, USA.
authors: J M
authors: JM
authors: Conlon
authors: J C
authors: JC
authors: Le Mevel
authors: D
authors: D
authors: Conklin
authors: L
authors: L
authors: Weaver
authors: D W
authors: DW
authors: Duff
authors: K R
authors: KR
authors: Olson
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D001158:Arteries / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects*; D001920:Bradykinin / Q000031:analogs & derivatives* / Q000302:isolation & purification / Q000494:pharmacology; D002317:Cardiovascular Agents / Q000302:isolation & purification / Q000494:pharmacology*; D002851:Chromatography, High Pressure Liquid; D066298:In Vitro Techniques; D007269:Injections, Intra-Arterial; D016234:Kallikrein-Kinin System; D008969:Molecular Sequence Data; D017686:Oncorhynchus mykiss; D014680:Veins / Q000187:drug effects
chemical_list: D002317:Cardiovascular Agents; C101532:bradykinin, Arg(0)-Trp(5)-Leu(8)-; D001920:Bradykinin